Moreover, they treated SESN2-silenced RKO cells with two representative chemotherapeutic agents, 5-fluorouracil (5-FU) and irinotecan (CPT-11), to asses if SESN2 may be important for the responsiveness of colon cancer cells to chemotherapeutic treatments. The gene discussed is SESN2; the disease is colonic neoplasm.